BERTIS Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BERTIS Inc. - overview
Established
2014
Location
Gyeonggi-do, -, South Korea
Primary Industry
Biotechnology
About
Based in Gyeonggi-do, South Korea, and founded in 2014, BERTIS Inc. operates as a proteomics technology company. In February 2024, BERTIS Inc. raised KRW 20 billion in pre-IPO funding from Korea Development Bank, Winvest Venture Capital, and DreamCIS.
As of 2024, the company is led by its co-CEOs, Dong-young Noh and Seung-man Han. BERTIS develops and offers proteomics-based clinical solutions for various cancer diseases. The company provides ProteoID (proteome integrated determination), which is a proteomics platform, and MASTOCHECK, a breast cancer early diagnosis blood test. The company plans to use the funds raised in February 2024 to market early diagnostic blood test products, extend its analysis service area, and expand its international business.
Current Investors
Meritz Fire & Marine Insurance, Smilegate Investment, Premier Partners
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Bioinformatics, Oncology/Cancer Treatment
Website
www.bertis.com
Verticals
Artificial Intelligence
Total Amount Raised
Subscriber access only
BERTIS Inc. - financials
| Fiscal Year Ended | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | 2,430,000 | 74,085,529 | 232,612,052 | - | - | - |
| % Revenue Growth (YoY) | - | - | 2948.8% | 214.0% | - | - | - |
| EBITDA (USD) | (1,356,482,278) | (2,473,727,637) | (5,345,943,949) | (13,876,833,401) | - | - | - |
| Operating Income (USD) | (1,433,283,468) | (3,080,657,801) | (6,026,872,888) | (14,420,524,401) | - | - | - |
| Operating Margin | - | (126776.0%) | (8135.0%) | (6199.4%) | - | - | - |
| % EBITDA Margin | - | (101799.5%) | (7215.9%) | (5965.7%) | - | - | - |
| NET Income (USD) | (1,474,186,019) | (2,969,577,820) | (7,812,265,169) | (23,642,688,998) | - | - | - |
| % Net Margin | - | (122204.8%) | (10544.9%) | (10164.0%) | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.